| Q34163174 | A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States |
| Q34210416 | Can we stop AIDS with antiretroviral-based treatment as prevention? |
| Q27026742 | Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review |
| Q37606376 | Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals |
| Q35397167 | HIV as a chronic disease considerations for service planning in resource-poor settings |
| Q34339533 | HIV treatment as prevention: the utility and limitations of ecological observation |
| Q36883784 | HIV-1 treatment as prevention: the good, the bad, and the challenges |
| Q35837727 | Increases in Condomless Sex in the Swiss HIV Cohort Study |
| Q36448286 | Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey |
| Q37833827 | Sexually transmitted infections: challenges ahead |
| Q35376376 | Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia |
| Q34858255 | The Achilles' Heel of HIV Treatment for Prevention: History of Sexually Transmitted Coinfections among People Living with HIV/AIDS Receiving Antiretroviral Therapies |
| Q36789681 | Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial |